Astec LifeSciences Limited (BOM:533138)

Market Cap	14.19B -20.9%
Revenue (ttm)	4.09B -1.7%
Net Income	-892.48M
EPS	-43.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	53.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,439
Average Volume	8,464
Open	635.05
Previous Close	649.45
Day's Range	616.90 - 643.45
52-Week Range	555.40 - 998.10
Beta	n/a
RSI	51.33
Earnings Date	Jan 30, 2026

About Astec LifeSciences

Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insec...

• Industry: Agricultural Chemicals
• Founded: 1994
• Employees: 555
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 533138

Financial Performance

In fiscal year 2025, Astec LifeSciences's revenue was 3.81 billion, a decrease of -16.86% compared to the previous year's 4.59 billion. Losses were -1.35 billion, 187.1% more than in 2024.